Trials / Sponsors / rEVO Biologics
rEVO Biologics
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia Preeclampsia | Phase 3 | 2014-07-11 |
| Completed | Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors Hemophilia A With Inhibitors, Hemophilia B With Inhibitors | Phase 3 | 2014-04-01 |
| Completed | A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients Wit Hemophilia | Phase 1 | 2012-10-01 |
| Completed | Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery o Antithrombin III Deficiency | Phase 3 | 2005-04-01 |
| Completed | Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) Antithrombin Deficiency, Congenital | Phase 3 | 2002-12-01 |